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INTRODUCTION 
The new report from the Office of the 
Surgeon General, Facing Addiction 
in America, is meant to be a call to 
action against the public health crisis of 
addiction. The report is densely packed 
with troubling statistics that highlight 
the prevalence of alcohol and substance 
misuse in the United States. In 2015, 20.8 
million people—nearly 8 percent of the 
US population—met the criteria for a 
substance use disorder (SUD) involving 
alcohol or illicit substances. As the report 
states, roughly 88,000 people die from 
alcohol-related deaths per year. In 2015, 
more than 52,000 deaths were attributed 
to drug overdose, which has claimed more 
lives in recent years largely due to a rise in 
opioid misuse. Substance misuse and SUDs 
cost the United States roughly $400 billion 
annually in health care and criminal justice 
expenses and lost worker productivity. 
Despite the heavy toll of substance misuse 
on individuals, families, and society, only 
about 10 percent of people who need help 
with an SUD actually receive it. In the 
face of this crisis and based on a growing 
body of neurobiological evidence, the 
report argues that addiction is a chronic 
disease of the brain that should be treated 
more like diabetes and less like an act of 
criminal misconduct.1
 The first report published by the 
Surgeon General’s Office was the 1964 
Smoking and Health: Report of the Advisory 
Committee of the Surgeon General of the 
Public Health Service, which examined the 
consequences of smoking and tobacco. 
That report is viewed as a watershed 
moment in the public health battle against 
smoking, and in the 50 years since its 
publication, numerous regulations on 
the production and sale of tobacco have 
been passed, which have contributed to 
considerable declines in smoking rates. 
The Surgeon General’s Office has published 
other reports since 1964, nearly all focused 
on tobacco and smoking, with some 
exceptions. Facing Addiction in America 
is the first report issued by that office on 
drugs, alcohol, and addiction, and Surgeon 
General Vivek Murthy hopes it will spark 
action on addiction the way the 1964 
report did on smoking.2
 The degree to which this report will 
shape policies and perceptions toward 
addiction remains to be seen, but its 
potential impact is significant. The report 
carries the medical and scientific credibility 
of one of the highest health offices in the 
country and has already garnered a large 
swath of media and public attention. It 
brings an authoritative voice to the current 
national debate over how to confront 
addiction in the face of rising rates of 
opioid-related overdoses and confirms 
what many observers have claimed—
that addiction requires compassion and 
treatment, not punishment. Because of its 
potential impact on policies directed toward 
drug use and addiction, it is important to 
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rightly states that addiction is not the 
result of “moral failings,” and should not 
be criminalized.5 This is a welcome change 
in message from the heydays of the war 
on drugs. Decades of experience show 
that punishment does not deter people 
from drug use and, insofar as it impedes 
implementation of more effective policy 
solutions, has damaging effects on public 
health. As the report argues, society stands 
to save money; decrease the transmission 
of communicable diseases; reduce 
incidences of homicide, suicide, motor 
vehicle accidents, and other injuries; and 
improve overall health and quality of life, 
if access to evidence-based treatment for 
SUDs is expanded. 
 The strong endorsement from the 
Surgeon General’s Office for integrated 
substance use care, expanded use of 
MAT, and an overall public health-based 
approach to addiction should send a clear 
message to policymakers and the public 
that an overhaul of US drug policy is long 
overdue. The wealth of research presented 
in the report on successful treatment 
methods and health care innovations that 
can improve access to and the quality of 
SUD care provides a guide for nonprofits 
and decision-makers at all levels of 
government looking for ways to better 
serve people with substance use disorders. 
SHORTCOMINGS OF THE SURGEON 
GENERAL’S REPORT
Neglects Heroin-Assisted Treatment
Despite the report’s general message 
of reform, there are several instances 
in which it does not go far enough. For 
example, while the report stresses the 
efficacy of MAT, it neglects heroin-
assisted treatment (HAT). The medications 
currently approved by the U.S. Food and 
Drug Administration (FDA) to treat opioid 
use disorders do not work for everyone, 
leading some to return to illicit use of 
heroin or other opioids. Recognizing this 
challenge, other countries—including 
Switzerland, Denmark, the Netherlands, 
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evaluate the claims made by the report. The 
following sections discuss the report and its 
implications in greater detail. 
WHAT THE SURGEON GENERAL’S 
REPORT GETS RIGHT
The Surgeon General’s report provides 
timely data on substance use trends, 
effective treatments, and developments 
in health care and insurance coverage 
for SUDs. It addresses critical limitations 
in SUD care that result from, among 
other things, inadequate or nonexistent 
insurance coverage for millions of 
Americans, especially minority and SUD 
populations. While the Affordable Care 
(ACA) and Mental Health Parity and 
Addiction Equity acts have made strides 
in reducing the uninsured population and 
requiring better coverage for substance use 
treatment, the report notes that limitations 
remain, including a lack of infrastructure 
needed to coordinate substance use with 
general health care; deficiencies in the SUD 
treatment workforce; and the absence 
of SUD treatment training from medical, 
psychiatry, psychology, and social work 
curricula.3
 Another important component of the 
report is its support for evidence-based 
care, including medication-assisted 
treatment (MAT), which is currently 
underutilized. MAT refers to the use of 
medications such as methadone and 
buprenorphine (for opioid use disorders) 
and naltrexone (for opioid and alcohol 
use disorders) to control the physical 
dependence aspects of addiction and to 
help users transition out of substance 
use. Despite numerous studies finding 
that MAT is highly effective, it is not 
always covered by insurance companies 
or offered as part of treatment programs, 
and some substance use providers 
continue to oppose it on the grounds that it 
“substitutes one addiction for another.”4
 In its “Vision for the Future” chapter, 
the Surgeon General’s report emphasizes 
a public health approach to drug use. It 
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Germany, and the United Kingdom—have 
made HAT a treatment option for opioid 
use disorders. Switzerland offers the most 
extensive evidence on the use of HAT. Since 
HAT first became available in the country 
in 1994, the spread of HIV and Hepatitis C 
have plummeted, overdoses from heroin 
have dropped to zero, and the number of 
addicts is decreasing by about 4 percent 
per year.6 Switzerland has also experienced 
substantial declines in problematic heroin 
use, which is at least partially attributed to 
HAT. HAT medicalized heroin use, changing 
the perception of heroin as a gateway to a 
rebellious counterculture to a “loser drug” 
associated with medical illness.7
 A common form of treatment in 
the United States in the nineteenth and 
early twentieth centuries,8 HAT is not 
currently available in this country. Given 
the evidence supporting its effectiveness, 
it should be. Yet the Surgeon General’s 
report, which so strongly emphasizes the 
need for evidence-based treatment, makes 
no mention of HAT. Substantial political 
barriers make the implementation of HAT a 
challenge, but at the very least, proposals 
could be put forth recommending that HAT 
be tested on a pilot basis. 
Maintains Support for Criminal Sanctions
The report is also too conservative in its 
call for criminal justice reform. It suggests 
that all levels of government “implement 
criminal justice reforms to transition to 
a less punitive and more health-focused 
approach.”9 Yet it maintains support for 
modest sanctions in juvenile and adult 
criminal justice settings as a tool to 
incentivize treatment compliance. Some 
studies indicate that coerced treatment 
can be just as effective as voluntary 
treatment. But the practical implications 
of a system that maintains the threat 
of sanctions to force someone into 
treatment can go beyond the intended 
effect. So long as a person is subject to 
incarceration or a criminal record for 
noncompliance, the consequences of the 
sanctions can result in worse outcomes 
for the individual than if no government 
intervention or assistance had taken 
place.10 Those who use drugs and commit 
offenses that can harm others, whether 
through intentional acts of violence or 
negligent acts such as driving under the 
influence, do require penalty. But for 
those who are simply using or possessing 
drugs without harming others, arrest, 
incarceration, and/or a criminal record are 
undeserved punishments. Decriminalizing 
all drug possession for personal use is 
the only way to ensure that individuals 
do not suffer the collateral consequences 
associated with the criminal justice 
system due to drug use and addiction. 
Oversimplifies Addiction
Punishment is an improper policy response 
to drug use and addiction for many 
reasons, but the report’s primary assertion 
regarding why addiction should not be 
criminalized—namely, that it is a brain 
disease—is a source of contention within 
the drug policy community. According to 
the report, whereas addiction was once 
perceived as a “moral failing,” it is now 
considered a... 
chronic illness characterized by clinically 
significant impairments in health, social 
function, and voluntary control over 
substance use. Although the mechanisms 
may be different, addiction has many 
features in common with disorders such 
as diabetes, asthma, and hypertension. 
All of these disorders are chronic, subject 
to relapse, and influenced by genetic, 
developmental, behavioral, social, and 
environmental factors.11
Is addiction a chronic disorder? 
The idea that addiction is “chronic” is 
inconsistent with decades of epidemiological 
data indicating that most drug users stop 
using on their own, without medical or 
therapeutic intervention.12 Multiple studies 
have found that drug use is greatest in 
young adulthood, and declines with age.13 
Data from the National Survey on Drug Use 
and Health (NSDUH), which the Surgeon 
General’s report cites frequently, indicate 
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behavioral change can be induced through 
positive incentives. 
 Each of these therapies has 
demonstrated effectiveness in helping 
people with SUDs, and the Surgeon 
General’s report supports the use of all 
three. It seems contradictory, however, 
to argue that addiction is a brain disease 
beyond the user’s control on the one hand 
and advocate for treatment that focuses 
on behavioral changes on the other. If 
change in a person’s behavior can change 
his or her state of addiction, this implies 
that the addiction is to some extent a 
function of individual choice. As has 
been noted elsewhere, it may be difficult 
to convince the public that addiction is 
primarily a brain disease when the most 
common forms of treatment continue 
to be those that focus on behavioral 
modification.20 The efficacy of behavioral 
therapies in treating SUDs substantially 
weakens the assertion that addiction is 
a disease of involuntary behavior. This 
contradiction requires a better explanation 
than what the report offers. 
 
What role does the brain play in the 
addiction process? 
The Surgeon General’s report attempts 
to qualify statements about the 
neurobiological process of addiction, 
explaining that not all drug users become 
addicted, and that social, behavioral, and 
environmental risk factors come into 
play. But this complexity is often lost. For 
instance, the report partially explains drug 
addiction as a process whereby the brain’s 
“survival systems are ‘hijacked’ by addictive 
substances.”21 This unscientific language 
suggests a fairly straightforward process 
of drug effects on the brain, but the last 
two decades of neurobiological research 
have found the effects that psychoactive 
substances have on the brain to be much 
more complicated than simply “hijacking” 
the brain’s reward centers, also affecting 
multiple neurotransmitter pathways and 
higher-order brain functions.22
 Explaining the very complicated 
process of addiction—still not fully 
that the prevalence of regular drug use 
(defined as drug use in the past 30 days) is 
highest among those between the ages of 
18 and 25 (22.3 percent) and is much lower 
among those 26 and older (8.2 percent).14 
The same pattern holds true for prevalence 
of an SUD. In 2015, 7 percent of 18 to 25 
year olds had an illicit drug use disorder in 
the past year, but only 2 percent of those 
26 and older did.15 For most people, even 
those with SUDs, drug use is not a chronic 
condition but one that diminishes with age. 
 One reason addiction is characterized 
as a chronic disorder is that at least half 
of those who enter treatment programs 
relapse, regardless of the drug in question 
or individual patient characteristics. The 
Surgeon General’s report points to data 
finding that it can take eight or nine years 
from first seeking treatment for a person 
to achieve “sustained recovery.”16 But it is 
quite possible, even likely, that those who 
seek out treatment represent the most 
severe forms of SUD, are more likely to 
suffer from additional disorders, and are 
therefore the least likely to stop using.17 
Because this population is atypical, findings 
about addiction and relapse taken from 
this group should not be used to make 
generalizations about the life course of 
drug addiction for other users.
Is a person who is addicted to drugs  
“out of control”? 
The portrayal of drug addiction as 
involuntary also is the subject of heated 
debate and is inconsistent with some of 
the treatment approaches advocated for 
in the Surgeon General’s report. The basis 
for cognitive-behavioral therapy (CBT) “is 
that substance use disorders develop, in 
part, as a result of maladaptive behavior 
patterns and dysfunctional thoughts.”18 
Twelve-Step Facilitation (TSF), most well-
known as Alcoholics Anonymous, focuses 
on individual therapy, group involvement, 
and “giving oneself to a higher 
power.”19 A third approach, contingency 
management, which provides drug users 
with a financial reward in exchange for 
abstaining from drug use, assumes that 
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understood by scientists—to a lay audience 
is challenging. But as the report recognizes, 
the scientific community needs to do a 
better job of communicating research to 
the public, and this report arguably does 
not do that. The neurobiological basis of 
addiction remains oversimplified and the 
role of external factors underemphasized. 
And even as the report recognizes the 
importance of and the need for research 
that addresses environmental risk factors, 
the call for future research focuses 
heavily on continuing study of the brain, 
missing an opportunity to call for greater 
integration of neurobiological research 
with epidemiological, psychological, and 
sociological research.
How do external factors affect the 
addiction process? 
Research focusing on environmental, 
behavioral, and social components of 
addiction is critical because data indicate 
that these factors increase one’s risk for 
an SUD. The Surgeon General’s report does 
emphasize this point. Yet in an interview 
with National Public Radio following the 
publication of the report, Surgeon General 
Vivek Murthy stated: “We now know from 
solid data that substance abuse disorders 
don’t discriminate. They affect the rich 
and the poor, all socioeconomic groups 
and ethnic groups. They affect people in 
urban areas and rural ones.”23 While true 
in a basic sense, to suggest that SUDs can 
affect anyone is somewhat misleading. 
Data from the NSDUH—the very data 
which the Surgeon General’s report relies 
on—show that statistically, some groups 
are more likely to use than others, and 
that certain risk factors make people much 
more likely to use drugs and develop SUDs. 
Several groups—males, people aged 18 to 
25, non-college graduates, sexual minority 
adults (defined as those who identify as 
lesbian, gay, or bisexual), and people living 
with mental illness—are at greater risk of 
developing an SUD than other groups.24
 As noted, the Surgeon General’s report 
discusses the role of various risk factors 
in contributing to SUDs, but this message 
is muddled by the Surgeon General’s own 
words. Emphasizing that some groups are 
at greater risk for drug use and misuse 
should not imply that the absence of 
identified risk factors makes a person 
immune from developing an SUD. But 
in the spirit of communicating honest, 
accurate information to the public about 
drug addiction, it is important to be clear 
about the respective roles of individual 
and environmental factors in explaining 
drug addiction.  
CONCLUSION
Facing Addiction in America is an important 
contribution to the public discourse on 
drug policy from one of the highest health 
offices in the United States. It stresses 
that addiction should be treated as a 
public health problem rather than a crime 
and, through an extensive review of data 
on effective treatment protocols, lends 
support to those who for years have been 
calling for drug policy reform. It provides 
information to the public about the nature 
and extent of drug use in the United States 
and environmental factors that provide 
protection against or increase one’s risk 
of developing an SUD. It is a useful guide 
for practitioners in the areas of social 
services, health care, and law enforcement 
regarding what types of programs are likely 
to have the greatest success in addressing 
addiction. It highlights several obstacles to 
more effective care and suggests ways in 
which various stakeholders can implement 
evidence-based practices for prevention 
and treatment. 
 For all its admirable qualities, there are 
other areas in which the report falls short. 
It misses an opportunity to bring heroin-
assisted treatment into the discussion 
of effective medication-assisted 
therapies for opioid use disorders. While 
it argues that addiction should not be 
criminalized, it stops short of supporting 
decriminalization of drug possession and 
maintains that legal sanctions can be an 
effective incentive for drug treatment, 
In fact, some people are 
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identity, mental health, 
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the Office of the Surgeon General and 
other proponents of the brain disease 
model of addiction readily acknowledge 
that there is more to addiction than the 
interplay between chemical substances 
and brain matter. Yet the role of external 
factors is not always given the emphasis 
it deserves, and the bulk of government-
funded research continues to focus almost 
exclusively on the neurobiological aspects 
of addiction, ignoring the need for greater 
integration of this research with research 
from other fields that may be able to 
address gaps in the brain disease model’s 
explanation of why some people are more 
susceptible to addiction than others. 
 Given that social, behavioral, and 
environmental factors are already at 
work before a person initiates drug use, 
explanations of addiction should start 
by discussing how these characteristics 
can affect drug use behavior before the 
neurobiological components of addiction 
are explained. This may seem like a 
small change, and it would not solve all 
of the conflict surrounding explanations 
for addiction. But it would depict the 
addiction process more accurately and 
would emphasize the respective roles of 
individual and environmental factors more 
appropriately. This may have important 
policy implications, as one concern is that 
the neglect of external variables has led 
to the underutilization of policy solutions 
designed to address such factors. 
 Explaining addiction in terms of its 
root environmental, social, and behavioral 
causes first and its neurobiological basis 
second would not support a return to 
the moralizing view of addiction, as it 
still maintains that people use drugs not 
because they are “bad” but because 
drugs offer reprieve from any number of 
miserable circumstances. But it does offer 
a less fatalistic picture of drug addiction, 
one in which an individual, through a 
change in circumstance, may change the 
desire to use drugs—and by extension, how 
that drug use is interpreted by the brain’s 
reward and pleasure systems. Future 
efforts to address drug addiction should 
not dealing with the reality of how these 
sanctions might be used in practice and 
the collateral consequences that an 
individual faces if sanctions are enforced. 
 While the report devotes substantial 
time to explaining how the likelihood of 
developing an SUD is affected by various 
environmental, social, and behavioral 
factors, the primary emphasis of the report 
is that addiction is a brain disease. At 
times, the explanation of how drug use can 
progress to addiction is oversimplified, and 
the report does not adequately address 
the inconsistency between the assertion 
that addiction is a chronic disease similar 
to diabetes or asthma, and yet one that 
also responds quite well to treatment 
focused on behavioral change. There is 
also confusion regarding the circumstances 
of addiction stemming from the Surgeon 
General’s own statement that addiction 
does not discriminate, while citing a 
wealth of data that suggest it actually 
does discriminate. In fact, some people are 
more likely to develop an SUD than others, 
depending on their gender, age, education, 
sexual identity, mental health, family 
situations, and other factors. 
A Way Forward
In the “Introduction” to the report, the 
Surgeon General states that addiction is 
not a “moral failing or character flaw”—it 
is a “chronic illness that we must approach 
with the same skill and compassion with 
which we approach heart disease, diabetes, 
and cancer.”25 Nearly all proponents of 
drug policy reform will agree that addiction 
is not a moral failing. Many also will 
agree that addiction has environmental, 
psychological, social, behavioral, and 
neurobiological components. But debate 
remains about how the process of 
addiction should be understood and 
explained. Those who are skeptical of the 
brain disease model of addiction argue 
that it oversimplifies a complex illness, 
ignores epidemiological data on addiction, 
and incorrectly describes it as a condition 
beyond the user’s control. For their part, 
Future efforts to address 
drug addiction should 
frame neurobiological 
explanations of 
addiction more squarely 
within the context of 
environmental risk 
factors, and should 
emphasize the need 
for social policies that 
address the underlying 
external causes of 
addiction.
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frame neurobiological explanations of 
addiction more squarely within the context 
of environmental risk factors, and should 
emphasize the need for social policies that 
address the underlying external causes of 
addiction. It is indeed time to change how 
we view drug addiction. Let’s get it right 
this time—by acknowledging the many 
complexities of addiction and the need for 
a holistic policy response. 
ENDNOTES
 1. Rose A. Rudd, Puja Seth, Felicita David, 
and Lawrence Scholl, “Increases in Drug 
and Opioid-Involved Overdose Deaths—
United States 2010-2015,” Morbidity and 
Mortality Weekly Report, December 16, 
2016, accessed February 7, 2017, https://
www.cdc.gov/mmwr/volumes/65/wr/
mm655051e1.htm.
 2. Office of the Surgeon General, 
Facing Addiction in America: The Surgeon 
General’s Report on Alcohol, Drugs, and 
Health, Washington, D.C.: U.S. Department 
of Health and Human Services, November 
2016, p. 12.
 3. Office of the Surgeon General, Facing 
Addiction in America, pp. 274-282.
 4. Office of the Surgeon General, Facing 
Addiction in America, p. 256.
 5. Office of the Surgeon General, Facing 
Addiction in America, p. 323-329.
 6. Citizens Opposing Prohibition, “Swiss 
Heroin-Assisted Treatment 1994-2016: 
Summary,” accessed January 10, 2017, 
http://www.citizensopposingprohibition.
org/resources/swiss-heroin-assisted-
treatment-1994-2009-summary/.
 7. Carlos Nordt and Rudolf Stohler, 
“Incidence of Heroin Use in Zurich, 
Switzerland: A Treatment Case Register 
Analysis,” The Lancet, 367 (2006): 1830-
1834, p.1834. 
 8. Prior to the passage of the 1914 
Harrison Narcotic Drug Act, it was common 
practice for physicians to prescribe opium 
to addicts to maintain their addiction. The 
passage of the 1914 Act restricted and 
eventually eliminated this practice. See 
Katharine A. Neill, “Tough on Drugs: Law 
and Order Dominance and the Neglect of 
Public Health in US Drug Policy,” World 
Medical and Health Policy, 6(2014): 375-394.
 9. Office of the Surgeon General, Facing 
Addiction in America, p. 336.
 10. The collateral consequences of a 
criminal record and incarceration are well 
documented. They include, but are not 
limited to, loss of education, employment, 
and housing opportunities; disruption of 
family structure; increased distrust of 
the legal system; and, in the case of a 
felony conviction, loss of voting rights. 
See Katharine A. Neill and William Martin, 
Marijuana Reform: Fears and Facts, Issue 
brief no. 02.04.15, Rice University’s Baker 
Institute for Public Policy, Houston, TX, 
2015, http://www.bakerinstitute.org/
files/8760/; Bruce Western and Becky 
Pettit, Collateral Costs: Incarceration’s 
Effect on Economic Mobility (Washington, 
D.C.: The Pew Charitable Trusts, 2010), 
http://www.pewtrusts.org/~/media/
legacy/uploadedfiles/pcs_assets/2010/
CollateralCosts1pdf.pdf; S. Lenton and P. 
Heale, “Arrest, court and social impacts of 
conviction for a minor cannabis offence 
under strict prohibition,” Contemporary 
Drug Problems 27 (2000): 805–833.
 11. Office of the Surgeon General, 
Facing Addiction in America, p. 65.
 12. William Martin and Jerry Epstein, 
“Rx for U.S. Drug Policy: A New Paradigm,” 
Baker Institute Policy Report Number 
63, Rice University’s Baker Institute for 
Public Policy, Houston, TX, 2015, http://
bakerinstitute.org/research/rx-us-drug-
policy-new-paradigm.
 13. Wilson M. Compton, Yonette 
F. Thomas, Kevin P. Conway, and James 
D. Colliver, “Developments in the 
Epidemiology of Drug Use and Drug Use 
Disorders,” American Journal of Psychiatry, 
162(2005): 1494-1502.
 14. Center for Behavioral Health 
Statistics and Quality, 2015 National 
Survey on Drug Use and Health: Detailed 
Tables, 2016. Rockville, MD: Substance 
Abuse and Mental Health Services 
Administration, p. 233.
8RICE UNIVERSITY'S BAKER INSTITUTE FOR PUBLIC POLICY // ISSUE BRIEF // 02.08.17
 15. Center for Behavioral Health 
Statistics, 2015 National Survey, p. 1503.
 16. Office of the Surgeon General, 
Facing Addiction in America, p. 228.
 17. Gene M. Heyman, Addiction: A 
Disorder of Choice (Cambridge, MA: Harvard 
University Press, 2009), p. 68.
 18. Office of the Surgeon General, 
Facing Addiction in America, p. 184.
 19. Office of the Surgeon General, 
Facing Addiction in America, p. 186.
 20. See Maia Szalavitz, “US Addiction 
Statistics are Dire. Small Changes Won’t 
Solve the Problem,” The Guardian, 
November 18, 2016, accessed January 
10, 2017, https://www.theguardian.com/
commentisfree/2016/nov/18/us-drug-
alcohol-addiction-statistics-treatment-
reform.
 21. Office of the Surgeon General, 
Facing Addiction in America, p. 69.
 22. Wayne Hall, Adrian Carter, and 
Cynthia Forlini, “The Brain Disease Model of 
Addiction: Is it Supported by the Evidence 
and has it Delivered on its Promises?”  
The Lancet Psychiatry 2(2015): 105-110.
 23. Vivek Murthy, interview with 
Morning Edition, “Surgeon General Murthy 
Wants America to Face Up to Addiction,” 
National Public Radio, November 
17, 2016, accessed January 10, 2017, 
http://www.npr.org/sections/health-
shots/2016/11/17/502402409/surgeon-
general-murthy-wants-america-to-face-
up-to-addiction.
 24. Center for Behavioral Health 
Statistics, 2015 National Survey.
 25. Office of the Surgeon General, 
Facing Addiction in America, p. 11.
AUTHOR
Katharine A. Neill, Ph.D., is the Alfred C. 
Glassell, III, Postdoctoral Fellow in Drug 
Policy. Her current research focuses on 
alternatives to incarcerations for drug 
offenders and expanding options for drug 
treatment and overdose prevention.
See more issue briefs at:
www.bakerinstitute.org/issue-briefs
This publication was written by a 
researcher (or researchers) who 
participated in a Baker Institute project. 
Wherever feasible, this research is 
reviewed by outside experts before it is 
released. However, the views expressed 
herein are those of the individual 
author(s), and do not necessarily 
represent the views of Rice University’s 
Baker Institute for Public Policy.
© 2017 Rice University’s Baker Institute 
for Public Policy 
This material may be quoted or 
reproduced without prior permission, 
provided appropriate credit is given to 
the author and Rice University’s Baker 
Institute for Public Policy.
Cover image courtesy of Facing 
Addiction.
Cite as:
Neill, Katharine A. 2017. Will the 
Surgeon General’s Report on  
Addiction Change How We Treat  
Drug Users? Issue brief no. 02.08.17. 
Rice University’s Baker Institute for 
Public Policy, Houston, Texas. 
